Cite
MLA Citation
Claudia Marchetti et al.. “Advances in anti-angiogenic agents for ovarian cancer treatment: The role of trebananib (AMG 386).” Critical reviews in oncology/hematology, vol. 94, no. 3, 2015, pp. 302–310. http://access.bl.uk/ark:/81055/vdc_100034056484.0x00000f